A primer towards evidence based medicine
Time to read: 3 minutes.
Early Market Access & Medicine Adoption
Most Keras360 calculators are highly customizable and can be enhanced with multiple predictive elements, rendering them a valuable primary resource for comparative studies. For further information, please consult the pre-clinical trial user interface; PCT .
Video: The user interface illustrates the incorporation of various calculations that support statistical analyses, facilitating informed decision-making regarding real-world evidence (RWE), early market access, and the successful adoption of medicines involving combination interventions. ♤
Case study: Pulmonary Arterial Hypertension 🫁 ⚡️
For the best visual experience, please enter full-screen mode and view the video once loading is complete.
Chinese: 真实世界证据 、数据
All rights reserved – ©The Waterhouse 水の家.
Music by Brice Davoli; Luxe – Love Stream.
Keras360 水の家 